{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:46:07Z","timestamp":1777754767419,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019006","name":"State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources","doi-asserted-by":"publisher","award":["CMEMR2020-A10"],"award-info":[{"award-number":["CMEMR2020-A10"]}],"id":[{"id":"10.13039\/501100019006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011785","name":"Science and Technology Department of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["AD23026252"],"award-info":[{"award-number":["AD23026252"]}],"id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2025GXNSFAA069585"],"award-info":[{"award-number":["2025GXNSFAA069585"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009007","name":"Guangxi Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109669","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:20:42Z","timestamp":1771773642000},"page":"109669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and biological evaluation of novel naphthoquinone [2,3-d] thiazole derivatives as potent 17\u03b2-HSD10 inhibitor"],"prefix":"10.1016","volume":"173","author":[{"given":"Erfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyun","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanqing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bioorg.2026.109669_bb0005","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.jmedchem.8b01530","article-title":"Amyloid-binding alcohol dehydrogenase (ABAD) inhibitors for the treatment of Alzheimer's disease","volume":"62","author":"Morsy","year":"2019","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109669_bb0010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/jpm15080346","article-title":"Roles of type 10 17\u03b2-Hydroxysteroid dehydrogenase in health and disease","volume":"15","author":"He","year":"2025","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jnc.15027","article-title":"Friend or enemy? Review of 17\u03b2-HSD10 and its role in human health or disease","volume":"155","author":"Vinklarova","year":"2020","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109669_bb0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11064-020-02970-y","article-title":"Interactions of 17\u03b2-Hydroxysteroid dehydrogenase type 10 and Cyclophilin D in Alzheimer's disease","volume":"45","author":"Kristofikova","year":"2020","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1523\/JNEUROSCI.0864-20.2021","article-title":"Sex-specific regulation of \u03b2-secretase: a novel estrogen response element (ERE)-dependent mechanism in Alzheimer's disease","volume":"42","author":"Cui","year":"2022","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109669_bb0030","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1007\/s12035-016-0181-z","article-title":"Chronic estradiol administration during the early stage of Alzheimer's disease pathology rescues adult hippocampal neurogenesis and ameliorates cognitive deficits in A\u03b21-42 mice","volume":"54","author":"Zheng","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-160258","article-title":"Early postmenopausal transdermal 17\u03b2-estradiol therapy and amyloid-\u03b2 deposition","volume":"53","author":"Kantarci","year":"2016","journal-title":"J. Alzheimer's Dis"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.neuroscience.2010.05.031","article-title":"Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease","volume":"169","author":"Amtul","year":"2010","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116092","article-title":"Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma","volume":"10","author":"Jayasena","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1074\/mcp.M114.040576","article-title":"Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation","volume":"14","author":"Shi","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mcn.2007.03.013","article-title":"Interaction of amyloid binding alcohol dehydrogenase\/A\u03b2 mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model","volume":"35","author":"Yao","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109669_bb0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.omtn.2021.11.019","article-title":"Implications of miR-148a-3p\/p35\/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt\/CREB in Alzheimer's disease","volume":"27","author":"Zeng","year":"2022","journal-title":"Mol. Ther-Nucl. Acids"},{"issue":"41","key":"10.1016\/j.bioorg.2026.109669_bb0065","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.0621-17.2017","article-title":"Inhibition of p25\/Cdk5 attenuates tauopathy in mouse and iPSC models of frontotemporal dementia","volume":"37","author":"Seo","year":"2017","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109669_bb0070","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1074\/jbc.M707932200","article-title":"Endophilin I expression is increased in the brains of Alzheimer disease patients","volume":"283","author":"Ren","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04389-0","article-title":"Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer's disease","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0080","first-page":"4897","article-title":"Endophilin 1 knockdown prevents synaptic dysfunction induced by oligomeric amyloid \u03b2","volume":"19","author":"Yin","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"22","key":"10.1016\/j.bioorg.2026.109669_bb0085","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1016\/j.bmcl.2018.09.031","article-title":"Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17\u03b2-hydroxysteroid dehydrogenase type 10","volume":"28","author":"Boutin","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109669_bb0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/1573406413666170109142725","article-title":"6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD\/17\u03b2-HSD10 and potential drugs for Alzheimer\u2019s disease treatment: design, synthesis and in vitro evaluation","volume":"13","author":"Benek","year":"2017","journal-title":"Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109669_bb0095","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/molecules24152757","article-title":"Novel benzothiazole-based Ureas as 17\u03b2-HSD10 inhibitors, a potential Alzheimer's disease treatment","volume":"24","author":"Aitken","year":"2019","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/2472555217697964","article-title":"In vitro assay development and HTS of small-molecule human ABAD\/17\u03b2-HSD10 inhibitors as therapeutics in Alzheimer's disease","volume":"22","author":"Aitken","year":"2017","journal-title":"SLAS Disc."},{"key":"10.1016\/j.bioorg.2026.109669_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112909","article-title":"Synthesis of 17\u03b2-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: selectivity, metabolic stability and enhanced potency","volume":"209","author":"Boutin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109669_bb0110","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/qua.21716","article-title":"Computational optimization of AG18051 inhibitor for amyloid-\u03b2 binding alcohol dehydrogenase enzyme","volume":"108","author":"Marques","year":"2008","journal-title":"Int. J. Quantum Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109669_bb0115","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/acschemneuro.2c00246","article-title":"Functionalized allopurinols targeting amyloid-binding alcohol dehydrogenase rescue A\u03b2-induced mitochondrial dysfunction","volume":"13","author":"Morsy","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109669_bb0120","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.bmcl.2006.05.099","article-title":"Identification of small-molecule inhibitors of the a\u03b2-ABAD interaction","volume":"16","author":"Xie","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0125","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cbdd.12068","article-title":"Structure-based design and synthesis of benzothiazole phosphonate analogs with inhibitors of human ABAD-a\u03b2 for treatment of Alzheimer's disease","volume":"81","author":"Valasani","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109669_bb0130","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.bmcl.2016.05.087","article-title":"Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD\/17\u03b2-HSD10 modulators for Alzheimer's disease treatment","volume":"26","author":"Hroch","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0135","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/ijms21062059","article-title":"Benzothiazolyl ureas are low micromolar and uncompetitive inhibitors of 17\u03b2-HSD10 with implications to Alzheimer's disease treatment","volume":"21","author":"Schmidt","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109669_bb0140","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1021\/acsmedchemlett.3c00355","article-title":"Nanomolar benzothiazole-based inhibitors of 17beta-HSD10 with cellular bioactivity","volume":"14","author":"Hanzlova","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109669_bb0145","doi-asserted-by":"crossref","first-page":"12116","DOI":"10.1021\/acsomega.3c10148","article-title":"C-3 steroidal Hemiesters as inhibitors of 17-\u03b2Hydroxysteroid dehydrogenase type 10","volume":"9","author":"Hanzlova","year":"2024","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109669_bb0150","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/cmdc.201200129","article-title":"Identification of a 17\u03b2-hydroxysteroid dehydrogenase type 10 steroidal inhibitor: a tool to investigate the role of type 10 in Alzheimer's disease and prostate cancer","volume":"7","author":"Ayan","year":"2012","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0155","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0040-4020(66)80038-8","article-title":"The constituents of Cacalia decomposita. Structures of maturin, maturinin, maturone, and maturinone","volume":"22","author":"Correa","year":"1966","journal-title":"Tetrahedron"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(01)00707-8","article-title":"Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants","volume":"174","author":"Itoigawa","year":"2001","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1021\/np030450f","article-title":"Antitumor agents. 233. Lantalucratins A-F, new cytotoxic naphthoquinones from Lantana involucrata","volume":"67","author":"Hayashi","year":"2004","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0170","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s12035-014-9088-8","article-title":"Methylene blue improves brain mitochondrial ABAD functions and decreases A\u03b2 in a neuroinflammatory Alzheimer's disease mouse model","volume":"53","author":"Zakaria","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2026.109669_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115593","article-title":"Development of submicromolar 17\u03b2-HSD10 inhibitors and their in vitro and in vivo evaluation","volume":"258","author":"Benek","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0180","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1039\/D4MD00861H","article-title":"Design and synthesis of 2-phenyl-1H-benzo[d]imidazole derivatives as 17\u03b2-HSD10 inhibitors for the treatment of Alzheimer's disease","volume":"16","author":"Liu","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/magnetochemistry4030032","article-title":"Structure confirmation and evaluation of a nonsteroidal inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 10","volume":"4","author":"Boutin","year":"2018","journal-title":"Magnetochemistry"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/jmbi.2000.4139","article-title":"Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)\/amyloid-\u03b2 binding alcohol dehydrogenase (ABAD)11Edited by I. A. Wilson","volume":"303","author":"Powell","year":"2000","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0195","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jmb.2004.07.071","article-title":"Crystal structure of human ABAD\/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics","volume":"342","author":"Kissinger","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109669_bb0200","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1016\/j.bmc.2008.09.043","article-title":"Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme","volume":"16","author":"Marques","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109669_bb0210","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1002\/jps.21745","article-title":"In vivo, in vitro and in silico methods for small molecule transfer across the BBB","volume":"98","author":"Jurgen","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2010.01.003","article-title":"Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability","volume":"74","author":"Mensch","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109669_bb0220","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.3390\/ijms22158096","article-title":"Roscovitine, a cyclin-dependent Kinase-5 inhibitor, decreases phosphorylated tau formation and death of retinal ganglion cells of rats after optic nerve crush","volume":"22","author":"Hirokawa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109669_bb0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neurobiolaging.2019.05.016","article-title":"ABAD\/17\u03b2-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP\/PS1 mice","volume":"81","author":"Xiao","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109669_bb0230","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00415-025-13101-4","article-title":"Advances in research on mitochondrial dysfunction in neurodegenerative diseases","volume":"272","author":"Zhang","year":"2025","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109669_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/cells14030229","article-title":"Mitochondrial alterations, oxidative stress, and therapeutic implications in Alzheimer's disease: a narrative review","volume":"14","author":"Spina","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0240","doi-asserted-by":"crossref","first-page":"8962","DOI":"10.1038\/s41598-020-65570-4","article-title":"Comparative effects of alpha- and gamma-tocopherol on mitochondrial functions in Alzheimer's disease in vitro model","volume":"10","author":"Pahrudin Arrozi","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bioorg.2026.109669_bb0250","article-title":"Protein kinases in Alzheimer's disease: pioneering insights into pathogenesis and therapeutic breakthroughs","author":"Lari","year":"2025","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109669_bb0260","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/ars.2016.6810","article-title":"Peroxiredoxin 5 decreases beta-amyloid-mediated cyclin-dependent kinase 5 activation through regulation of Ca2+-mediated Calpain activation","volume":"27","author":"Park","year":"2017","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0265","article-title":"Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer's disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+\/Calpain\/Cdk5-mediated mitochondrial fragmentation","volume":"14","author":"Park","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-5362.394816","article-title":"The therapeutic value of thiazole and thiazolidine derivatives in Alzheimer's disease: a systematic literature review","volume":"19","author":"Abdollahi","year":"2024","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.109669_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120986","article-title":"Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: mechanisms and possible therapeutic interventions","volume":"308","author":"Maitra","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.109669_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106924","article-title":"Contributions of major tau kinase activation and phospho-tau accumulation to cortical and hippocampal tangle formation and cognition in older adults","volume":"210","author":"Hernandez-Hernandez","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0285","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41398-025-03551-9","article-title":"CDK5-mediated hyperphosphorylation of Tau217 impairs neuronal synaptic structure and exacerbates cognitive impairment in Alzheimer's disease","volume":"15","author":"Fu","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109669_bb0290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/a-2238-1384","article-title":"Targeting abnormal tau phosphorylation for Alzheimer's therapeutics","volume":"56","author":"Singh","year":"2024","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12576-020-00757-y","article-title":"Tolfenamic acid inhibits GSK-3\u03b2 and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models","volume":"70","author":"Zhang","year":"2020","journal-title":"J. Physiol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109669_bb0300","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","article-title":"Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios","volume":"80","author":"Janelidze","year":"2023","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109669_bb0305","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/ijms26094271","article-title":"From synaptic plasticity to neurodegeneration: BDNF as a transformative target in medicine","volume":"26","author":"Toader","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12017-025-08857-x","article-title":"Unlocking Alzheimer's disease: the role of BDNF signaling in neuropathology and treatment","volume":"27","author":"Alqahtani","year":"2025","journal-title":"NeuroMolecular Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10048-025-00821-y","article-title":"Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms","volume":"26","author":"Abbas","year":"2025","journal-title":"Neurogenetics"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109669_bb0320","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/1871527323666230912090856","article-title":"Role of BDNF signaling in the neuroprotective and memory-enhancing effects of flavonoids in Alzheimer's disease","volume":"23","author":"Amidfar","year":"2024","journal-title":"CNS Neurol. Disord."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109669_bb0325","first-page":"104","article-title":"Mechanism of promoting BDNF expression in brain of Alzheimer's disease patients through exercise training","volume":"41","author":"Wang","year":"2025","journal-title":"Chin. J. Neuroanat."},{"key":"10.1016\/j.bioorg.2026.109669_bb0330","first-page":"1","article-title":"Microbiota-gut-brain axis and probiotics: potential therapeutic strategies for treating Alzheimer's disease","author":"Ajith","year":"2025","journal-title":"Nutr. Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0335","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4103\/NRR.NRR-D-24-00107","article-title":"Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease","volume":"20","author":"Seplovich","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2026.109669_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.583097","article-title":"The potential roles of ghrelin in metabolic syndrome and secondary symptoms of Alzheimer's disease","volume":"14","author":"Kim","year":"2020","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109669_bb0345","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/cells10102581","article-title":"Inflammatory Cascade in Alzheimer's disease pathogenesis: a review of experimental findings","volume":"10","author":"de Oliveira","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0350","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-142730","article-title":"Localization and trafficking of amyloid-\u03b2 protein precursor and secretases: impact on Alzheimer's disease","volume":"45","author":"Agostinho","year":"2015","journal-title":"J. Alzheimer's Dis"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109669_bb0355","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/138920008786485227","article-title":"Artificial membrane assays to assess permeability","volume":"9","author":"Faller","year":"2008","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109669_bb0360","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109669_bb0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:06:05Z","timestamp":1777464365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"alternative-id":["S0045206826002051"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109669","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel naphthoquinone [2,3-d] thiazole derivatives as potent 17\u03b2-HSD10 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109669"}}